Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  AstraZeneca plc    AZN

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

UK Health Watchdog Backs Lung Cancer Drug From Roche

05/09/2012 | 07:16pm US/Eastern

The U.K.'s health-care watchdog said in final draft guidance Thursday that it is recommending the use of Roche Holding AG's (ROG.VX) Tarceva as a treatment option for advanced-stage lung-cancer patients.

The National Institute for Health and Clinical Excellence, known as NICE, decides what medicines should be used in the U.K.'s publicly-funded National Health Service. It said the drug--whose chemical name is erlotinib--is a cost-effective use of NHS resources.

NICE, which has already recommended AstraZeneca PLC's (>> AstraZeneca plc) Iressa, or gefitinib, for non-small-cell lung cancer, said that while there isn't any trial data directly comparing the two drugs, clinical specialists say the drugs are "very similar and equally as effective."

"We are pleased to be able to recommend another treatment option for this stage of the disease," said NICE Director Carole Longson.

The watchdog said its decision to back the drug came after it requested more information about it from the Swiss drug maker.

Roche wasn't immediately available for comment.

NICE said the draft guidance is now with consultees, who have the opportunity to appeal against it.

-By Marta Falconi, Dow Jones Newswires; +41 43 443 8043; marta.falconi@dowjones.com

Stocks mentioned in the article : AstraZeneca plc, AstraZeneca plc
React to this article
Latest news on ASTRAZENECA PLC
07/31 ASTRAZENECA : Astra proves its mettle after snubbing Pfizer
07/31 ROCHE BEARER SHARE : submits filing to FDA for companion diagnostic for non-smal..
07/31 ASTRAZENECA : Revenue change at AstraZeneca in
07/31 ASTRAZENECA : *socgen cuts astrazeneca price target to 6400 pence - 'buy'
07/31 ASTRAZENECA : *rpt/s&p capital iq raises astrazeneca to 'buy' ('hold') - price t..
07/30 ASTRAZENECA : Notice of Results
07/30 ASTRAZENECA : *s&p capital iq raises astrazeneca to 'buy' ('hold') - price targe..
07/30DJAstraZeneca Boosted by Licensing Deals -- 2nd Update
07/30 ASTRAZENECA : Ups Revenue Guidance As First Half Profit Falls (UPDATE)
07/30 ASTRAZENECA : IN THE KNOW: Analysts Positive As AstraZeneca Interims Beats Forec..
Advertisement
Chart
Duration : Period :
AstraZeneca plc Technical Analysis Chart | AZN | GB0009895292 | 4-Traders
Income Statement Evolution
More Financials